Rate My Professor Eva Dimitriadis

Professor Dimitriadis's research specializes in reproductive biology, with a focus on infertility, endometrial receptivity to implanting embryos, endometrial-trophoblast interactions during implantation, and the development of non-invasive biomarkers of implantation potential. Her investigations include microRNA regulation of these processes, novel sustained-release targeted delivery systems, new non-hormonal contraceptives that prevent sexually transmitted diseases, and treatments for endometrial cancer. She has authored numerous high-impact publications, including 'Interleukin-11 alters placentation and causes preeclampsia features in mice' in PNAS (2015), 'Transcytosis of IL-11 and Apical Redirection of gp130 Is Mediated by IL-11α Receptor' in Cell Reports (2016), 'Fertile ground: human endometrial programming and lessons in health and disease' in Nature Reviews Endocrinology (2016), and 'Targeting Interleukin-11 receptor-α impairs human endometrial cancer cell proliferation and invasion in vitro and reduces tumour growth and metastasis in vivo' in Molecular Cancer Therapeutics (2016). Her work features translational applications in pre-clinical trials and fosters collaborations with institutions such as Monash IVF, the Walter and Eliza Hall Institute, University of Melbourne, University of Tokyo, Commonwealth Serum Laboratories, and the Karolinska Institutet, contributing to SDG 3 (Good Health and Well-being) and SDG 5 (Gender Equality).